• Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
  • The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
  • This web site is a service of Prostate Cancer International.

    pcai_cmyk

  • Other PCI web sites

  • The "New" Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services.

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The "New" Prostate Cancer InfoLink is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

    • Perspective Confidentiality Disclosure Reliability Courtesy

Please participate in on-line, QoL, survey-based, prostate cancer study

A research team at the National Institutes of Health and the Johns Hopkins University Bloomberg School of Public Health is seeking prostate cancer patients willing to complete an on-line survey as part of a study to determine how men with prostate cancer cope with their disease, how their quality of life (QoL) is affected, and how they think about themselves compared to others. … READ MORE …

Immediate vs. deferred radical prostatectomy for localized prostate cancer

A retrospective analysis of data from the Swedish National Prostate Cancer Register suggests that deferring radical prostatectomy for a year or more has minimal impact on prostate cancer-specific survival for men with localized prostate cancer. … READ MORE …

The natural history of low-risk prostate cancer

In a presentation given at the annual meeting of the American Urology Association earlier this year, researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) provided some interesting data on the natural history of prostate cancer in patients initially diagnosed with low-risk disease. … READ MORE …

The “empowered” patient — an article in USA Today

An article by Mary Brophy Marcus in USA Today discusses the role of the patient today in acting as his or her own advocate when it comes to testing, costs, and health care decisions. … READ MORE …

A Presidential Proclamation for Prostate Cancer Awareness Month

We are pleased to note that the following Presidential Proclamation was issued by the White House yesterday: … READ MORE …

Does taking a statin lower PSA in men being tested for prostate cancer risk?

Ever since it was recognized that there might be an association between taking statins (as a preventive treatment for elevated cholesterol levels) and risk for prostate cancer (which is now disputed), there has been an associated question as to whether men taking statins generally had a lower PSA level than men who were not, and what that might mean. … READ MORE …

Effects of prostate biopsy on voiding and erectile function

A new study from a German research group is likely to fuel concerns about some of the risks associated with prostate biopsy. … READ MORE …

A randomized, controlled trial of diet and exercise for men on ADT

A research team in Belfast, Northern Ireland, has initiated a randomized, controlled clinical trial to assess the impact of diet and exercise on body composition, fatigue, and quality of life for patients who have are about to start androgen deprivation therapy (ADT). … READ MORE …

Intra-operative “fire” during RALP — a surgical complication to be avoided!

A recent paper in European Urology reports the first (known) case of an “intra-abdominal combustion” during a robot-assisted laparoscopic radical prostatectomy (RALP). … READ MORE …

From suspicion to treatment: is time to action appropriate?

Two newly published articles suggest that – among a small group of Canadian patients and a large cohort of US veterans — there was a significant time interval from initial suspicion of prostate cancer to definitive treatment (where necessary). But was this time interval appropriate? … READ MORE …

Statins and cancer: is the idea that statins affect prostate cancer a “bust?”

According to the international Cholesterol Treatment Trialists’ Collaboration, based on data from more than 166,000 clinical trial participants, there is no evidence whatsoever that statin therapy either causes or prevents cancer. … READ MORE …

The value of second-line treatment for men with biochemical recurrence

Biochemical failure (also known as biochemical recurrence) after first-line treatment for prostate cancer is assessed based on a rising PSA level. This is a relatively common event and can happen shortly after first line treatment or many years later. The problem is that we really don’t know how important biochemical recurrence is in an individual patient at a specific point in time. After all, if a biochemical recurrence is never going to lead to clinical symptoms of prostate cancer (let alone prostate cancer-specific mortality), why would one want to treat it? … READ MORE …

Adjuvant and neoadjuvant use of ADT in management of prostate cancer today

The use of androgen deprivation therapy (ADT) alone and in conjunction with other forms of treatment for the management of patients with relatively early stages of prostate cancer (i.e., cancer that is not definitively at least lymph node positive) has been increasingly called into question. … READ MORE …

Let’s light the White House blue in September (redux!)

Last May, Dan Zenka of the Prostate Cancer Foundation (motivated by his own recent diagnosis) first suggested the idea of lighting the White House blue in September to celebrate Prostate Cancer Awareness Month. Now there’s been a formal request supported by many of the leading prostate cancer advocacy organizations (including Dan and the Prostate Cancer Foundation). … READ MORE …

Diet and supplement use in the Prostate Cancer Prevention Trial

A new report states that there is minimal evidence of any well-defined effect of diet, nutrition or supplement use on the prevention of prostate cancer based on data collected as part of the Prostate Cancer Prevention Trial (PCPT). … READ MORE …